Search Results 41-50 of 17085 for Alkaptonuria

  1. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.

  2. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  3. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  4. Immunosuppressants · Cyclosporine (Gengraf, Neoral, Sandimmune). · Tacrolimus (Astagraf XL, Prograf, Envarsus XR).

  5. Clinical Outcomes with Avacopan for Granulomatosis with Polyangiitis and Microscopic Polyangiitis - Mayo Clinic

    The purpose of this study is to measure remission outcomes in people with GPA/MPA using avacopan. Participation eligibility. Participant eligibility includes ...

  6. Polycystic kidney disease

    Other genes that cause kidney cyst disease, such as DNAJB11. A way to use CT and MRI scans to classify polycystic kidney disease and select people for clinical ...

  7. To Evaluate The Long-term Safety And Tolerability Of Acoramidis In Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) - Mayo Clinic

    About this study. The AG10-504 study is an open-label extension study of acoramidis in participants with newly diagnosed transthyretin amyloid ...

  8. High blood protein When to see a doctor - Mayo Clinic

    High blood protein is an increase in the concentration of protein in the bloodstream. The medical term for high blood protein is hyperproteinemia.

  9. OTC Deficiency Study - Mayo Clinic

    About this study. The objectives of this study are to perform genomic testing and trio analysis on specimens from three deceased patients with partial OTC ...

  10. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...